Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma

International Journal of Cancer

Volumn 129, Issue 12, 2011, Pages 2816-2824

  Cancemi, Lisa ^a   Romei, Cristina ^a   Bertocchi, Sara ^a   Tarrini, Giulia ^a   Spitaleri, Irene ^b   Cipollini, Monica ^a   Landi, Debora ^a   Garritano, Sonia ^c   Pellegrini, Giovanni ^d   Cristaudo, Alfonso ^a   Pinchera, Aldo ^a   Barale, Roberto ^a   Elisei, Rossella ^a   Landi, Stefano ^a   Gemignani, Federica ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d CISANELLO HOSPITAL   (Italy)

Author keywords

association study; genetic susceptibility; polymorphism; thyroid cancer; tumor suppressor gene; WWOX

Indexed keywords

ALANINE; AMINO ACID; GUANINE; PROLINE; OXIDOREDUCTASE; TUMOR SUPPRESSOR PROTEIN; WWOX PROTEIN, HUMAN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CODON; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC MARKER; GENETIC SELECTION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID PAPILLARY CARCINOMA; TUMOR SUPPRESSOR GENE; WWOX GENE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; SUPPRESSOR GENE; THYROID TUMOR;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENES, SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OXIDOREDUCTASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84855169843     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25937     Document Type: Article

References (44)

1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR,. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments]. Cancer 1998; 83: 2638-48. (Pubitemid 29019586)
2. Franceschi S, Boyle P, Maisonneuve P, La VC, Burt AD, Kerr DJ, Macfarlane GJ,. The epidemiology of thyroid carcinoma. Crit Rev Oncog 1993; 4: 25-52.
3. Farbota LM, Calandra DB, Lawrence AM, Paloyan E,. Thyroid carcinoma in Graves' disease. Surgery 1985; 98: 1148-53. (Pubitemid 16104737)
4. Pacini F, Elisei R, Di Coscio GC, Anelli S, Macchia E, Concetti R, Miccoli P, Arganini M, Pinchera A,. Thyroid carcinoma in thyrotoxic patients treated by surgery. J Endocrinol Invest 1988; 11: 107-12. (Pubitemid 18070528)
5. Segal K, Ben-Bassat M, Avraham A, Har-El G, Sidi J,. Hashimoto's thyroiditis and carcinoma of the thyroid gland. Int Surg 1985; 70: 205-9. (Pubitemid 16131950)
6. Cardis E, Howe G, Ron E, Bebeshko V, Bogdanova T, Bouville A, Carr Z, Chumak V, Davis S, Demidchik Y, Drozdovitch V, Gentner N, et al. Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 2006; 26: 127-40. (Pubitemid 43861071)
7. Hancock SL, Cox RS, McDougall IR,. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991; 325: 599-605.
8. Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, Ribeiro RC, Relling MV, Kun LE, Evans WE, Hudson MM,. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 2003; 349: 640-9. (Pubitemid 36975996)
9. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD, Jr., Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141: 259-77.
10. Schlumberger M, Cailleux AF, Suarez HG, De VF,. Irradiation and second cancers. The thyroid as a case in point. C R Acad Sci III 1999; 322: 205-13.
11. Harach HR, Williams GT, Williams ED,. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology 1994; 25: 549-61. (Pubitemid 24381103)
12. Malchoff CD, Malchoff DM,. Familial papillary thyroid carcinoma. Cancer Treat Res 2004; 122: 381-7.
13. Goodman MT, Kolonel LN, Wilkens LR,. The association of body size, reproductive factors and thyroid cancer. Br J Cancer 1992; 66: 1180-4. (Pubitemid 23006165)
14. McTiernan A, Weiss NS, Daling JR,. Incidence of thyroid cancer in women in relation to known or suspected risk factors for breast cancer. Cancer Res 1987; 47: 292-5. (Pubitemid 17002138)
15. Ron E, Lunenfeld B, Menczer J, Blumstein T, Katz L, Oelsner G, Serr D,. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987; 125: 780-90. (Pubitemid 17066477)
16. Dal Maso L, La VC, Franceschi S, Preston-Martin S, Ron E, Levi F, Mack W, Mark SD, McTiernan A, Kolonel L, Mabuchi K, Jin F, et al. A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control 2000; 11: 137-44. (Pubitemid 30088392)
17. Dal ML, Bosetti C, La VC, Franceschi S,. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 2009; 20: 75-86.
18. Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P, Mangion J, Hamoudi R, Rosenblatt J, Buu P, Sun S, Stoffer SS, et al. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 1997; 61: 1123-30. (Pubitemid 27492321)
19. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D,. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 1998; 63: 1743-8. (Pubitemid 30415737)
20. Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V, Arnold A, Malchoff DM,. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 2000; 85: 1758-64. (Pubitemid 32269272)
21. McKay JD, Lesueur F, Jonard L, Pastore A, Williamson J, Hoffman L, Burgess J, Duffield A, Papotti M, Stark M, Sobol H, Maes B, et al. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 2001; 69: 440-6. (Pubitemid 32695216)
22. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 2009; 41: 460-4.
23. Ohashi J, Tokunaga K,. The power of genome-wide association studies of complex disease genes: statistical limitations of indirect approaches using SNP markers. J Hum Genet 2001; 46: 478-82. (Pubitemid 32744121)
24. Nannya Y, Taura K, Kurokawa M, Chiba S, Ogawa S,. Evaluation of genome-wide power of genetic association studies based on empirical data from the HapMap project. Hum Mol Genet 2007; 16: 2494-505. (Pubitemid 47500635)
25. Pritchard JK,. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001; 69: 124-37. (Pubitemid 32614025)
26. Schork NJ, Murray SS, Frazer KA, Topol EJ,. Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 2009; 19: 212-9.
27. Baida A, Akdi M, Gonzalez-Flores E, Galofre P, Marcos R, Velazquez A,. Strong association of chromosome 1p12 loci with thyroid cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2008; 17: 1499-504.
28. Chiang FY, Wu CW, Hsiao PJ, Kuo WR, Lee KW, Lin JC, Liao YC, Juo SH,. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin Cancer Res 2008; 14: 5919-24.
29. Hernandez A, Xamena N, Surralles J, Galofre P, Velazquez A, Creus A, Marcos R,. Role of GST and NAT2 polymorphisms in thyroid cancer. J Endocrinol Invest 2008; 31: 1025-31.
30. Ho T, Li G, Zhao C, Zheng R, Wei Q, Sturgis EM,. Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis. Head Neck 2008; 30: 297-305. (Pubitemid 351480744)
31. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV, Ward LS,. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett 2004; 210: 151-7. (Pubitemid 38748685)
32. Eng C. The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors. Recent Prog Horm Res 1999; 54: 441-52.
33. Sturgis EM, Zhao C, Zheng R, Wei Q,. Radiation response genotype and of differentiated thyroid cancer: a case-control analysis. Laryngoscope 2005; 115: 938-45. (Pubitemid 40776979)
34. Finn SP, Smyth P, Cahill S, Streck C, O'Regan EM, Flavin R, Sherlock J, Howells D, Henfrey R, Cullen M, Toner M, Timon C, et al. Expression microarray analysis of papillary thyroid carcinoma and benign thyroid tissue: emphasis on the follicular variant and potential markers of malignancy. Virchows Arch 2007; 450: 249-60. (Pubitemid 46376555)
35. Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K, Gauger P, Doherty G, et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene 2005; 24: 6646-56. (Pubitemid 41486795)
36. Murphy KM, Chen F, Clark DP,. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling. Hum Pathol 2008; 39: 420-6. (Pubitemid 351186691)
37. Yano Y, Uematsu N, Yashiro T, Hara H, Ueno E, Miwa M, Tsujimoto G, Aiyoshi Y, Uchida K,. Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma. Clin Cancer Res 2004; 10: 2035-43. (Pubitemid 38375564)
38. van WT, Lombaerts M, van Roon EH, Philippo K, Baelde HJ, Szuhai K, Cornelisse CJ, Cleton-Jansen AM,. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q. Breast Cancer Res 2005; 7: R998-1004.
39. Aqeilan RI, Croce CM,. WWOX in biological control and tumorigenesis. J Cell Physiol 2007; 212: 307-10. (Pubitemid 47025619)
40. Dias EP, Pimenta FJ, Sarquis MS, Dias Filho MA, Aldaz CM, Fujii JB, Gomez RS, De ML,. Association between decreased WWOX protein expression and thyroid cancer development. Thyroid 2007; 17: 1055-9. (Pubitemid 350207764)
41. Sbrana I, Veroni F, Nieri M, Puliti A, Barale R,. Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer. Genes Chromosomes Cancer 2006; 45: 429-36.
42. Lu PJ, Zhou XZ, Shen M, Lu KP,. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 1999; 283: 1325-8.
43. Maeda N, Semba S, Nakayama S, Yanagihara K, Yokozaki H,. Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations. Virchows Arch 2010; 457: 423-32.
44. Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, Scott D, Porteous DJ, Smyth JF, Gabra H, Watson JE,. WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci USA 2001; 98: 11417-22. (Pubitemid 32928743)